Patient selection for immunotherapy in head and neck cancer

Pierluigi Bonomo¹, Ester Orlandi², Paolo Bossi³

Affiliations

¹ Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.
² Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy, Pavia, Italy.
³ Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health-Medical Oncology, University of Brescia, ASST-Spedali Civili, Brescia 25123, Italy. Electronic address: paolo.bossi@unibs.it.

PMID: 34197752
DOI: 10.1016/S1470-2045(21)00237-0

Comment

Patient selection for immunotherapy in head and neck cancer

Pierluigi Bonomo et al. Lancet Oncol. 2021 Jul.

. 2021 Jul;22(7):e290.

doi: 10.1016/S1470-2045(21)00237-0.

Authors

Pierluigi Bonomo¹, Ester Orlandi², Paolo Bossi³

Affiliations

¹ Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.
² Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy, Pavia, Italy.
³ Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health-Medical Oncology, University of Brescia, ASST-Spedali Civili, Brescia 25123, Italy. Electronic address: paolo.bossi@unibs.it.

PMID: 34197752
DOI: 10.1016/S1470-2045(21)00237-0

No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment in

Patient selection for immunotherapy in head and neck cancer - Authors' reply.
Lee NY, Ferris RL, De Beukelaer S, Cohen E. Lee NY, et al. Lancet Oncol. 2021 Jul;22(7):e291-e292. doi: 10.1016/S1470-2045(21)00339-9. Lancet Oncol. 2021. PMID: 34197753 No abstract available.

Comment on

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Lee NY, Ferris RL, Psyrri A, Haddad RI, Tahara M, Bourhis J, Harrington K, Chang PM, Lin JC, Razaq MA, Teixeira MM, Lövey J, Chamois J, Rueda A, Hu C, Dunn LA, Dvorkin MV, De Beukelaer S, Pavlov D, Thurm H, Cohen E. Lee NY, et al. Lancet Oncol. 2021 Apr;22(4):450-462. doi: 10.1016/S1470-2045(20)30737-3. Lancet Oncol. 2021. PMID: 33794205 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Patient selection for immunotherapy in head and neck cancer

Affiliations

Patient selection for immunotherapy in head and neck cancer

Authors

Affiliations

Conflict of interest statement

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical